Clinical Trials

NCT04325828 | ACTIVE_NOT_RECRUITING | PHASE2

31 participants

A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-04-07

Completion:

2021-06-09

Conditions

• Salivary Gland Neoplasms

Interventions

• DRUG

Results Available

NCT04319068 | ACTIVE_NOT_RECRUITING

600 participants

Sodium Storage in Singaporeans

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2019-07-02

Completion:

2028-12-31

Conditions

• Healthy
• Hypertension

No Results Yet

NCT04289480 | ACTIVE_NOT_RECRUITING

164 participants

Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2020-07-30

Completion:

2022-04-22

Conditions

• Intracranial Aneurysm

Interventions

• DEVICE

No Results Yet

NCT04273945 | ACTIVE_NOT_RECRUITING | PHASE3

935 participants

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-06-30

Completion:

2025-10-07

Conditions

• Pulmonary Arterial Hypertension

Interventions

• DRUG

No Results Yet

NCT04267705 | ACTIVE_NOT_RECRUITING | NA

103 participants

Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-02-24

Completion:

2023-05-30

Conditions

• Insulin Sensitivity
• Overweight or Obesity
• Inflammatory Response

Interventions

• OTHER

No Results Yet

NCT04256486 | COMPLETED | NA

321 participants

Family Model Diabetes Self-Management Education in Faith Based Organizations

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2022-04-21

Completion:

2025-08-22

Conditions

• Type 2 Diabetes

Interventions

• BEHAVIORAL

No Results Yet

NCT04253392 | ACTIVE_NOT_RECRUITING

500 participants

RETHINK REFLUX Registry

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2020-07-08

Completion:

2032-07-31

Conditions

• Gastroesophageal Reflux

Interventions

• DEVICE

No Results Yet

NCT04216342 | RECRUITING | PHASE1

64 participants

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2021-09-29

Completion:

2027-06-30

Conditions

• Cardiovascular Disease

Interventions

• BIOLOGICAL

No Results Yet

NCT04205500 | ACTIVE_NOT_RECRUITING | NA

30 participants

Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2017-09-01

Completion:

2026-12-31

Conditions

• Juvenile Idiopathic Arthritis

Interventions

• OTHER

No Results Yet

NCT04195217 | COMPLETED | NA

86 participants

" Application of Art Therapy in Oncology: Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease"

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-01-07

Completion:

2025-03-17

Conditions

• Therapy-Associated Cancer

Interventions

• BEHAVIORAL

Results Available

NCT04181684 | ACTIVE_NOT_RECRUITING | NA

39 participants

LITT Followed by Hypofractionated RT for Recurrent Gliomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-01-08

Completion:

2026-12-31

Conditions

• Glioblastoma
• Brain Tumor
• Glioma
• Neoplasms

Interventions

• DEVICE
• RADIATION

No Results Yet

NCT04175600 | ACTIVE_NOT_RECRUITING | PHASE3

138 participants

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-01-16

Completion:

2024-10-11

Conditions

• Hypertension, Pulmonary

Interventions

• DRUG

Results Available

NCT04170283 | ACTIVE_NOT_RECRUITING | PHASE3

955 participants

A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of Zanubrutinib

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-01-16

Completion:

2026-12-31

Conditions

• B-cell Malignancies

Interventions

• DRUG

No Results Yet

NCT04126161 | COMPLETED | NA

18 participants

HIP: Hip Imaging Protocol

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-11-01

Completion:

2025-07-10

Conditions

• Metabolic Profiling Muscle

Interventions

• PROCEDURE
• DEVICE

Results Available

NCT04108195 | ACTIVE_NOT_RECRUITING | PHASE1

290 participants

A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-02-21

Completion:

2027-04-07

Conditions

• Multiple Myeloma

Interventions

• DRUG

No Results Yet

NCT04090710 | COMPLETED | PHASE2

66 participants

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-01-29

Completion:

2026-04-23

Conditions

• Metastatic Renal Cell Carcinoma

Interventions

• DRUG
• RADIATION

No Results Yet

NCT04065438 | RECRUITING | NA

35 participants

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2020-01-01

Completion:

2027-09-30

Conditions

• Focal Segmental Glomerulosclerosis

Interventions

• DEVICE

No Results Yet

NCT04039087 | COMPLETED | PHASE2/PHASE3

31 participants

Sildenafil Exercise: Role of PDE5 Inhibition

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-09-05

Completion:

2024-06-30

Conditions

• Cystic Fibrosis

Interventions

• DRUG

Results Available

NCT04023552 | COMPLETED | PHASE3

8323 participants

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-12-12

Completion:

2026-07-16

Conditions

• Cardiovascular Disease and Lipoprotein(a)

Interventions

• DRUG

No Results Yet

NCT04014348 | RECRUITING

250 participants

Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2021-10-20

Completion:

2026-12-10

Conditions

• Cardiovascular (CV) Risk

No Results Yet

NCT03964090 | ACTIVE_NOT_RECRUITING | PHASE2

48 participants

Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-06-27

Completion:

2027-07-01

Conditions

• Central Nervous System Lymphoma
• Secondary Central Nervous System Lymphoma

Interventions

• DRUG

No Results Yet

NCT03963349 | ACTIVE_NOT_RECRUITING

150 participants

THERMOCOOL SMARTTOUCH®SF Catheters With Ablation Index Study

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2019-06-24

Completion:

2026-12-31

Conditions

• Paroxysmal Atrial Fibrillation

No Results Yet

NCT03937882 | COMPLETED | PHASE3

700 participants

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-05-24

Completion:

2020-11-08

Conditions

• Dry Eye Syndromes
• Dry Eye

Interventions

• DRUG

Results Available

NCT03854318 | RECRUITING

1000 participants

Longitudinal Studies of Patient With FPDMM

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2019-03-28

Completion:

2028-12-31

Conditions

• Inherited Hematological Diseases
• Rare Diseases
• FPDMM

No Results Yet

NCT03841617 | RECRUITING | PHASE2

30 participants

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-07-29

Completion:

2035-11-01

Conditions

• Thyroid Cancer

Interventions

• DRUG
• RADIATION
• OTHER

No Results Yet

NCT03793179 | ACTIVE_NOT_RECRUITING | PHASE3

600 participants

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-04-05

Completion:

2027-09-30

Conditions

• Lung Non-Squamous Non-Small Cell Carcinoma
• Stage IIIB Lung Cancer AJCC v8
• Stage IIIC Lung Cancer AJCC v8
• Stage IV Lung Cancer AJCC v8

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT03783143 | COMPLETED

8524 participants

Prevalence and Incidence of Lassa Virus Infection in Southern Mali

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2020-12-04

Completion:

2024-07-25

Conditions

• Lassa Virus Infection

No Results Yet

NCT03775265 | ACTIVE_NOT_RECRUITING | PHASE3

475 participants

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-06-03

Completion:

2027-06-01

Conditions

• Bladder Urothelial Carcinoma
• Muscle Invasive Bladder Carcinoma
• Stage II Bladder Cancer AJCC v8
• Stage IIIA Bladder Cancer AJCC v8

Interventions

• DRUG
• PROCEDURE
• OTHER
• RADIATION

No Results Yet

NCT03767244 | ACTIVE_NOT_RECRUITING | PHASE3

2517 participants

A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-06-11

Completion:

2026-12-01

Conditions

• Prostatic Neoplasms

Interventions

• DRUG

No Results Yet

NCT03737981 | ACTIVE_NOT_RECRUITING | PHASE3

465 participants

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-01-31

Completion:

2025-01-17

Conditions

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Interventions

• DRUG
• BIOLOGICAL
• OTHER

Results Available

NCT03701282 | ACTIVE_NOT_RECRUITING | PHASE3

720 participants

Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-02-12

Completion:

2028-05-07

Conditions

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL
• OTHER

No Results Yet

NCT03660826 | ACTIVE_NOT_RECRUITING | PHASE2

288 participants

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-09-27

Completion:

2024-12-06

Conditions

• Endometrial Adenocarcinoma
• Endometrial Mixed Cell Adenocarcinoma
• Endometrial Serous Adenocarcinoma
• Endometrial Undifferentiated Carcinoma
• Endometrioid Adenocarcinoma
• Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

Results Available

NCT03651505 | ACTIVE_NOT_RECRUITING

782 participants

X-linked Hypophosphatemia Disease Monitoring Program

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-28

Start Date:

2018-07-16

Completion:

2032-12-31

Conditions

• X-linked Hypophosphatemia
• Hypophosphatemic Rickets

Interventions

• OTHER

No Results Yet

NCT03619551 | ACTIVE_NOT_RECRUITING | PHASE2

56 participants

Conditioning SCID Infants Diagnosed Early

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-10-22

Completion:

2027-12-01

Conditions

• SCID

Interventions

• DRUG
• DEVICE

No Results Yet

NCT03595124 | ACTIVE_NOT_RECRUITING | PHASE2

15 participants

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2019-01-08

Completion:

2024-09-30

Conditions

• Metastatic Renal Cell Carcinoma
• Stage III Renal Cell Cancer AJCC v8
• Stage IV Renal Cell Cancer AJCC v8
• TFE3-Rearranged Renal Cell Carcinoma
• Unresectable Renal Cell Carcinoma

Interventions

• DRUG
• BIOLOGICAL

Results Available

NCT03523442 | ACTIVE_NOT_RECRUITING | PHASE1

19 participants

A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-08-31

Completion:

2019-07-09

Conditions

• Prostatic Neoplasms

Interventions

• DRUG

No Results Yet

NCT03492177 | ACTIVE_NOT_RECRUITING | PHASE2

63 participants

A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-07-23

Completion:

2022-03-28

Conditions

• Pulmonary Arterial Hypertension

Interventions

• DRUG

Results Available

NCT03473743 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

125 participants

A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-04-05

Completion:

2022-09-30

Conditions

• Urothelial Carcinoma

Interventions

• DRUG

Results Available

NCT03457948 | COMPLETED | PHASE2

32 participants

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-08-27

Completion:

2025-07-31

Conditions

• Metastatic Malignant Neoplasm in the Liver
• Neuroendocrine Neoplasm

Interventions

• PROCEDURE
• BIOLOGICAL
• DEVICE

Results Available

NCT03431350 | ACTIVE_NOT_RECRUITING | PHASE2

136 participants

A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-28

Start Date:

2018-03-02

Completion:

2021-08-31

Conditions

• Prostatic Neoplasms, Castration-Resistant

Interventions

• DRUG

Results Available